Flomics Biotech is a company from Barcelona operating in the genomics and liquid biopsy space. By combining Next-generation sequencing (NGS) technology with bioinformatics data analysis powered by machine learning we developed a liquid biopsy test that can provide clinically relevant information for the early detection and management of cancer and other complex diseases. Everything from a blood sample.
Flomics also offers tailored genomics solutions depending on your project needs, from data generation to data analysis and bioinformatics. From patient screening to large biomarker discovery projects we provide full support to any basic and translational research, pre-clinical or clinical project.